申请人:Boehringer Ingelheim GmbH
公开号:US04006246A1
公开(公告)日:1977-02-01
Pharmaceutical dosage unit compositions containing as an active ingredient a compound of the formula ##STR1## wherein R.sub.1 is hydrogen, lower alkanoyl, benzoyl or halobenzoyl, R.sub.2 is hydrogen, chlorine or bromine, R.sub.3 is carboxyl or lower carbalkoxy, and R.sub.4 and R.sub.5 are each hydrogen, alkyl of 1 to 5 carbon atoms, mono- or di-hydroxy-(alkyl of 1 to 5 carbon atoms), alkenyl or 2 to 4 carbon atoms, cycloalkyl of 5 to 7 carbon atoms, mono- or di-hydroxy-(cycloalkyl of 5 to 7 carbon atoms) or benzyl, Or a non-toxic, pharmacologically acceptable acid addition salt thereof; and a method of using the same as anti-ulcerogenics, secretolytics, antitussives, and stimulants of the production of the surfactant or antiatelectasis factor of the alveoli.
含有化合物的制药剂量单位组成物的活性成分的公式为##STR1##其中R.sub.1是氢,低级烷酰基,苯甲酰基或卤代苯甲酰基,R.sub.2是氢,氯或溴,R.sub.3是羧基或较低的羧酸烷氧基,而R.sub.4和R.sub.5分别是氢,1至5个碳原子的烷基,1至5个碳原子的单或二羟基烷基,2至4个碳原子的烯基,5至7个碳原子的环烷基,5至7个碳原子的单或二羟基环烷基或苄基,或其无毒、药理学上可接受的酸加成盐;以及将其用作抗溃疡原剂、分泌抑制剂、止咳剂和肺泡表面活性剂或抗肺不张因子的刺激剂的方法。